Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Lévesque JP[au]:

Search results

Items: 1 to 50 of 116

1.

CD27, CD201, FLT3, CD48, and CD150 cell surface staining identifies long-term mouse hematopoietic stem cells in immunodeficient non-obese diabetic severe combined immune deficient derived strains.

Nowlan B, Williams ED, Doran MR, Levesque JP.

Haematologica. 2019 May 9. pii: haematol.2018.212910. doi: 10.3324/haematol.2018.212910. [Epub ahead of print]

2.

Complement receptor C3aR1 controls neutrophil mobilization following spinal cord injury through physiological antagonism of CXCR2.

Brennan FH, Jogia T, Gillespie ER, Blomster LV, Li XX, Nowlan B, Williams GM, Jacobson E, Osborne GW, Meunier FA, Taylor SM, Campbell KE, MacDonald KP, Levesque JP, Woodruff TM, Ruitenberg MJ.

JCI Insight. 2019 May 2;4(9). pii: 98254. doi: 10.1172/jci.insight.98254. eCollection 2019 May 2.

3.

Inhibition of JAK1/2 Tyrosine Kinases Reduces Neurogenic Heterotopic Ossification After Spinal Cord Injury.

Alexander KA, Tseng HW, Fleming W, Jose B, Salga M, Kulina I, Millard SM, Pettit AR, Genêt F, Levesque JP.

Front Immunol. 2019 Mar 7;10:377. doi: 10.3389/fimmu.2019.00377. eCollection 2019.

4.

Mode rotation control in a tokamak with a feedback-driven biased electrode.

Brooks JW, Stewart IG, Boyer MD, Levesque JP, Mauel ME, Navratil GA.

Rev Sci Instrum. 2019 Feb;90(2):023503. doi: 10.1063/1.5062271.

PMID:
30831681
5.

HIF prolyl hydroxylase inhibitor FG-4497 enhances mouse hematopoietic stem cell mobilization via VEGFR2/KDR.

Bisht K, Brunck ME, Matsumoto T, McGirr C, Nowlan B, Fleming W, Keech T, Magor G, Perkins AC, Davies J, Walkinshaw G, Flippin L, Winkler IG, Levesque JP.

Blood Adv. 2019 Feb 12;3(3):406-418. doi: 10.1182/bloodadvances.2018017566.

6.

Blocking neuromuscular junctions with botulinum toxin A injection enhances neurological heterotopic ossification development after spinal cord injury in mice.

Salga M, Tseng HW, Alexander KA, Jose B, Vaquette C, Debaud C, Gatin L, Genêt F, Levesque JP.

Ann Phys Rehabil Med. 2019 May;62(3):189-192. doi: 10.1016/j.rehab.2019.01.005. Epub 2019 Feb 1. No abstract available.

PMID:
30716518
7.

Self-repopulating recipient bone marrow resident macrophages promote long-term hematopoietic stem cell engraftment.

Kaur S, Raggatt LJ, Millard SM, Wu AC, Batoon L, Jacobsen RN, Winkler IG, MacDonald KP, Perkins AC, Hume DA, Levesque JP, Pettit AR.

Blood. 2018 Aug 16;132(7):735-749. doi: 10.1182/blood-2018-01-829663. Epub 2018 Jun 26.

PMID:
29945953
8.

Macrophages Driving Heterotopic Ossification: Convergence of Genetically-Driven and Trauma-Driven Mechanisms.

Levesque JP, Sims NA, Pettit AR, Alexander KA, Tseng HW, Torossian F, Genêt F, Lataillade JJ, Le Bousse-Kerdilès MC.

J Bone Miner Res. 2018 Feb;33(2):365-366. doi: 10.1002/jbmr.3346. Epub 2017 Dec 27. No abstract available.

9.

CD169+ macrophages are critical for osteoblast maintenance and promote intramembranous and endochondral ossification during bone repair.

Batoon L, Millard SM, Wullschleger ME, Preda C, Wu AC, Kaur S, Tseng HW, Hume DA, Levesque JP, Raggatt LJ, Pettit AR.

Biomaterials. 2019 Mar;196:51-66. doi: 10.1016/j.biomaterials.2017.10.033. Epub 2017 Oct 22.

10.

Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications.

Torossian F, Guerton B, Anginot A, Alexander KA, Desterke C, Soave S, Tseng HW, Arouche N, Boutin L, Kulina I, Salga M, Jose B, Pettit AR, Clay D, Rochet N, Vlachos E, Genet G, Debaud C, Denormandie P, Genet F, Sims NA, Banzet S, Levesque JP, Lataillade JJ, Le Bousse-Kerdilès MC.

JCI Insight. 2017 Nov 2;2(21). pii: 96034. doi: 10.1172/jci.insight.96034.

11.

Peripheral denervation participates in heterotopic ossification in a spinal cord injury model.

Debaud C, Salga M, Begot L, Holy X, Chedik M, de l'Escalopier N, Torossian F, Levesque JP, Lataillade JJ, Le Bousse-Kerdilès MC, Genêt F.

PLoS One. 2017 Aug 30;12(8):e0182454. doi: 10.1371/journal.pone.0182454. eCollection 2017.

12.

HIF-1α-stabilizing agent FG-4497 rescues human CD34+ cell mobilization in response to G-CSF in immunodeficient mice.

Nowlan B, Futrega K, Brunck ME, Walkinshaw G, Flippin LE, Doran MR, Levesque JP.

Exp Hematol. 2017 Aug;52:50-55.e6. doi: 10.1016/j.exphem.2017.05.004. Epub 2017 May 17.

PMID:
28527810
13.

Engineering a humanized bone organ model in mice to study bone metastases.

Martine LC, Holzapfel BM, McGovern JA, Wagner F, Quent VM, Hesami P, Wunner FM, Vaquette C, De-Juan-Pardo EM, Brown TD, Nowlan B, Wu DJ, Hutmacher CO, Moi D, Oussenko T, Piccinini E, Zandstra PW, Mazzieri R, Lévesque JP, Dalton PD, Taubenberger AV, Hutmacher DW.

Nat Protoc. 2017 Apr;12(4):639-663. doi: 10.1038/nprot.2017.002. Epub 2017 Mar 2.

PMID:
28253234
14.

Cellular players of hematopoietic stem cell mobilization in the bone marrow niche.

Tay J, Levesque JP, Winkler IG.

Int J Hematol. 2017 Feb;105(2):129-140. doi: 10.1007/s12185-016-2162-4. Epub 2016 Dec 10. Review.

PMID:
27943116
15.

It takes nerve to fight back: The significance of neural innervation of the bone marrow and spleen for immune function.

Jung WC, Levesque JP, Ruitenberg MJ.

Semin Cell Dev Biol. 2017 Jan;61:60-70. doi: 10.1016/j.semcdb.2016.08.010. Epub 2016 Aug 11. Review.

PMID:
27523920
16.

Role of bone marrow macrophages in controlling homeostasis and repair in bone and bone marrow niches.

Kaur S, Raggatt LJ, Batoon L, Hume DA, Levesque JP, Pettit AR.

Semin Cell Dev Biol. 2017 Jan;61:12-21. doi: 10.1016/j.semcdb.2016.08.009. Epub 2016 Aug 10. Review.

PMID:
27521519
17.

A Validated Preclinical Animal Model for Primary Bone Tumor Research.

Wagner F, Holzapfel BM, Thibaudeau L, Straub M, Ling MT, Grifka J, Loessner D, Lévesque JP, Hutmacher DW.

J Bone Joint Surg Am. 2016 Jun 1;98(11):916-25. doi: 10.2106/JBJS.15.00920.

PMID:
27252436
18.

CD169(+) macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer.

Wu AC, He Y, Broomfield A, Paatan NJ, Harrington BS, Tseng HW, Beaven EA, Kiernan DM, Swindle P, Clubb AB, Levesque JP, Winkler IG, Ling MT, Srinivasan B, Hooper JD, Pettit AR.

J Pathol. 2016 Jun;239(2):218-30. doi: 10.1002/path.4718. Epub 2016 Apr 27.

PMID:
27174786
19.

Mobilization of hematopoietic stem cells with highest self-renewal by G-CSF precedes clonogenic cell mobilization peak.

Winkler IG, Wiercinska E, Barbier V, Nowlan B, Bonig H, Levesque JP.

Exp Hematol. 2016 Apr;44(4):303-14.e1. doi: 10.1016/j.exphem.2016.01.001. Epub 2016 Jan 29.

PMID:
26827874
20.

Fms-like tyrosine kinase 3 (Flt3) ligand depletes erythroid island macrophages and blocks medullar erythropoiesis in the mouse.

Jacobsen RN, Nowlan B, Brunck ME, Barbier V, Winkler IG, Levesque JP.

Exp Hematol. 2016 Mar;44(3):207-12.e4. doi: 10.1016/j.exphem.2015.11.004. Epub 2015 Dec 1.

PMID:
26607596
21.

Filling the void: allogeneic myeloid cells for transplantation.

Schwaber JL, Brunck ME, Lévesque JP, Nielsen LK.

Curr Opin Hematol. 2016 Jan;23(1):72-7. doi: 10.1097/MOH.0000000000000205. Review.

PMID:
26554894
22.

Design and installation of a ferromagnetic wall in tokamak geometry.

Hughes PE, Levesque JP, Rivera N, Mauel ME, Navratil GA.

Rev Sci Instrum. 2015 Oct;86(10):103504. doi: 10.1063/1.4932312.

PMID:
26520952
23.

Tissue engineered humanized bone supports human hematopoiesis in vivo.

Holzapfel BM, Hutmacher DW, Nowlan B, Barbier V, Thibaudeau L, Theodoropoulos C, Hooper JD, Loessner D, Clements JA, Russell PJ, Pettit AR, Winkler IG, Levesque JP.

Biomaterials. 2015 Aug;61:103-14. doi: 10.1016/j.biomaterials.2015.04.057. Epub 2015 May 19.

PMID:
26001075
24.

Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML.

Forristal CE, Brown AL, Helwani FM, Winkler IG, Nowlan B, Barbier V, Powell RJ, Engler GA, Diakiw SM, Zannettino AC, Martin S, Pattabiraman D, D'Andrea RJ, Lewis ID, Levesque JP.

Leukemia. 2015 Oct;29(10):2075-85. doi: 10.1038/leu.2015.102. Epub 2015 Apr 29.

PMID:
25921247
25.

Neurological heterotopic ossification following spinal cord injury is triggered by macrophage-mediated inflammation in muscle.

Genêt F, Kulina I, Vaquette C, Torossian F, Millard S, Pettit AR, Sims NA, Anginot A, Guerton B, Winkler IG, Barbier V, Lataillade JJ, Le Bousse-Kerdilès MC, Hutmacher DW, Levesque JP.

J Pathol. 2015 Jun;236(2):229-40. doi: 10.1002/path.4519. Epub 2015 Mar 26.

PMID:
25712044
26.

Concise review: humanized models of tumor immunology in the 21st century: convergence of cancer research and tissue engineering.

Holzapfel BM, Wagner F, Thibaudeau L, Levesque JP, Hutmacher DW.

Stem Cells. 2015 Jun;33(6):1696-704. doi: 10.1002/stem.1978. Review.

27.

Macrophages and regulation of erythropoiesis.

Jacobsen RN, Perkins AC, Levesque JP.

Curr Opin Hematol. 2015 May;22(3):212-9. doi: 10.1097/MOH.0000000000000131.

PMID:
25693142
28.

HIF-1α is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1α.

Forristal CE, Nowlan B, Jacobsen RN, Barbier V, Walkinshaw G, Walkley CR, Winkler IG, Levesque JP.

Leukemia. 2015 Jun;29(6):1366-78. doi: 10.1038/leu.2015.8. Epub 2015 Jan 12.

29.

Fast, multi-channel real-time processing of signals with microsecond latency using graphics processing units.

Rath N, Kato S, Levesque JP, Mauel ME, Navratil GA, Peng Q.

Rev Sci Instrum. 2014 Apr;85(4):045114. doi: 10.1063/1.4870901.

PMID:
24784666
30.

Mobilization with granulocyte colony-stimulating factor blocks medullar erythropoiesis by depleting F4/80(+)VCAM1(+)CD169(+)ER-HR3(+)Ly6G(+) erythroid island macrophages in the mouse.

Jacobsen RN, Forristal CE, Raggatt LJ, Nowlan B, Barbier V, Kaur S, van Rooijen N, Winkler IG, Pettit AR, Levesque JP.

Exp Hematol. 2014 Jul;42(7):547-61.e4. doi: 10.1016/j.exphem.2014.03.009. Epub 2014 Apr 8.

PMID:
24721610
31.

Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes.

Pattabiraman DR, McGirr C, Shakhbazov K, Barbier V, Krishnan K, Mukhopadhyay P, Hawthorne P, Trezise A, Ding J, Grimmond SM, Papathanasiou P, Alexander WS, Perkins AC, Levesque JP, Winkler IG, Gonda TJ.

Blood. 2014 Apr 24;123(17):2682-90. doi: 10.1182/blood-2012-02-413187. Epub 2014 Mar 4.

PMID:
24596419
32.

Targeting the hypoxia-sensing pathway in clinical hematology.

Forristal CE, Levesque JP.

Stem Cells Transl Med. 2014 Feb;3(2):135-40. doi: 10.5966/sctm.2013-0134. Epub 2013 Dec 26.

33.

The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor.

Karpova D, Dauber K, Spohn G, Chudziak D, Wiercinska E, Schulz M, Pettit AR, Levesque JP, Romagnoli B, Patel K, Chevalier E, Dembowsky K, Bonig H.

Leukemia. 2013 Dec;27(12):2322-31. doi: 10.1038/leu.2013.266. Epub 2013 Sep 12.

34.

In situ "artificial plasma" calibration of tokamak magnetic sensors.

Shiraki D, Levesque JP, Bialek J, Byrne PJ, DeBono BA, Mauel ME, Maurer DA, Navratil GA, Pedersen TS, Rath N.

Rev Sci Instrum. 2013 Jun;84(6):063502. doi: 10.1063/1.4808366.

PMID:
23822340
35.

It takes nerves to recover from chemotherapy.

Levesque JP, Winkler IG.

Nat Med. 2013 Jun;19(6):669-71. doi: 10.1038/nm.3231. No abstract available.

PMID:
23744143
36.

A niche in a dish: pericytes support HSC.

Levesque JP.

Blood. 2013 Apr 11;121(15):2816-8. doi: 10.1182/blood-2013-02-485144.

PMID:
23580633
37.

[E-selectin, a key regulator of the division of hematopoietic stem cells and their resistance to chemotherapy].

Levesque JP, Winkler IG.

Med Sci (Paris). 2013 Mar;29(3):249-51. doi: 10.1051/medsci/2013293007. Epub 2013 Mar 27. French. No abstract available.

38.

Engraftment Outcomes after HPC Co-Culture with Mesenchymal Stromal Cells and Osteoblasts.

Cook MM, Doran MR, Kollar K, Barbier V, Winkler IG, Levesque JP, Brooke G, Atkinson K.

J Clin Med. 2013 Sep 23;2(3):115-35. doi: 10.3390/jcm2030115.

39.

Pharmacologic stabilization of HIF-1α increases hematopoietic stem cell quiescence in vivo and accelerates blood recovery after severe irradiation.

Forristal CE, Winkler IG, Nowlan B, Barbier V, Walkinshaw G, Levesque JP.

Blood. 2013 Jan 31;121(5):759-69. doi: 10.1182/blood-2012-02-408419. Epub 2012 Dec 14.

PMID:
23243286
40.

Nichotherapy for stem cells: there goes the neighborhood.

Levesque JP, Winkler IG, Rasko JE.

Bioessays. 2013 Mar;35(3):183-90. doi: 10.1002/bies.201200111. Epub 2012 Nov 5. Review.

PMID:
23129341
41.

Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance.

Winkler IG, Barbier V, Nowlan B, Jacobsen RN, Forristal CE, Patton JT, Magnani JL, Lévesque JP.

Nat Med. 2012 Nov;18(11):1651-7. doi: 10.1038/nm.2969. Epub 2012 Oct 21.

PMID:
23086476
42.

B-lymphopoiesis is stopped by mobilizing doses of G-CSF and is rescued by overexpression of the anti-apoptotic protein Bcl2.

Winkler IG, Bendall LJ, Forristal CE, Helwani F, Nowlan B, Barbier V, Shen Y, Cisterne A, Sedger LM, Levesque JP.

Haematologica. 2013 Mar;98(3):325-33. doi: 10.3324/haematol.2012.069260. Epub 2012 Aug 28.

43.

Mobilization of hematopoietic stem cells by depleting bone marrow macrophages.

Barbier V, Winkler IG, Lévesque JP.

Methods Mol Biol. 2012;904:117-38. doi: 10.1007/978-1-61779-943-3_11.

PMID:
22890928
44.

N(o)-cadherin role for HSCs.

Levesque JP.

Blood. 2012 Jul 12;120(2):237-8. doi: 10.1182/blood-2012-05-431148.

PMID:
22791770
45.

A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity.

Oancea I, Png CW, Das I, Lourie R, Winkler IG, Eri R, Subramaniam N, Jinnah HA, McWhinney BC, Levesque JP, McGuckin MA, Duley JA, Florin TH.

Gut. 2013 Apr;62(4):594-605. doi: 10.1136/gutjnl-2012-302274. Epub 2012 Jul 7.

PMID:
22773547
46.

Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation.

Winkler IG, Pettit AR, Raggatt LJ, Jacobsen RN, Forristal CE, Barbier V, Nowlan B, Cisterne A, Bendall LJ, Sims NA, Lévesque JP.

Leukemia. 2012 Jul;26(7):1594-601. doi: 10.1038/leu.2012.17. Epub 2012 Jan 23.

PMID:
22266913
47.

Flow cytometry measurement of bone marrow perfusion in the mouse and sorting of progenitors and stems cells according to position relative to blood flow in vivo.

Barbier V, Winkler IG, Wadley R, Lévesque JP.

Methods Mol Biol. 2012;844:45-63. doi: 10.1007/978-1-61779-527-5_4.

PMID:
22262434
48.

Flow cytometry analysis of cell cycling and proliferation in mouse hematopoietic stem and progenitor cells.

Barbier V, Nowlan B, Lévesque JP, Winkler IG.

Methods Mol Biol. 2012;844:31-43. doi: 10.1007/978-1-61779-527-5_3.

PMID:
22262433
49.

Mobilisation strategies for normal and malignant cells.

To LB, Levesque JP, Herbert KE, Winkler IG, Bendall LJ, Hiwase DK, Antonenas V, Rice AM, Gottlieb D, Mills AK, Rasko JE, Larsen S, Beligaswatte A, Nilsson SK, Cooney JP, Cambareri AC, Lewis ID.

Pathology. 2011 Oct;43(6):547-65. doi: 10.1097/PAT.0b013e32834a9eb8. Review.

PMID:
21921732
50.

How I treat patients who mobilize hematopoietic stem cells poorly.

To LB, Levesque JP, Herbert KE.

Blood. 2011 Oct 27;118(17):4530-40. doi: 10.1182/blood-2011-06-318220. Epub 2011 Aug 10. Review.

PMID:
21832280

Supplemental Content

Loading ...
Support Center